Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Andrew J Stacy, PhD |
Stacy T32 |
University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) |
1016232 |
8/1/2020-6/30/2021 |
$48,312 |
Biplab DasGupta, PhD |
Biguanide Sensitivity of Glioma Stem Cells |
Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) |
R01NS099162 |
12/1/2020-11/30/2021 |
$341,397 |
Biplab DasGupta, PhD |
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and Challenges |
Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) |
R01NS114074 |
12/1/2020-11/30/2021 |
$415,647 |
Biplab DasGupta, PhD |
Co-targeting S6 and TAM kinases in PTEN-deficient Glioblastoma |
University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) |
12653-002 |
12/1/2020-11/30/2021 |
$21,630 |
James Geller, MD |
Geller Vice Chair Renal Tumor Committee |
Children's Oncology Group (National Cancer Institute) National Institues of Health (NIH) |
9500080220-XX |
3/1/2020-2/28/2021 |
$7,754 |
James Geller, MD |
Geller COG NCTN Study Chair |
Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) |
Geller CHOP 20110742 |
3/1/2020-2/28/2021 |
$7,754 |
James Geller, MD |
Geller AHEP 1531 COG Chair |
Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) |
U10CA180886 |
3/1/2020-2/28/2021 |
$15,508 |
James Geller, MD |
Geller AREN 1921 COG Study |
Children's Oncology Group |
AREN1921 |
6/1/2020-5/31/2025 |
$82,212 |
James Geller, MD |
Geller AREN 1921 Study Chair |
Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) |
U10CA180886 |
3/1/2020-2/28/2021 |
$7,754 |
John P Perentesis, MD |
COG NCTN Workload Intensity General |
Children's Hospital of Philadelphia (National Institutes of Health) National Institues of Health (NIH) |
2U10CA180886 |
3/1/2020-2/28/2021 |
$132,150 |
Kanimozhi Vairamani, PhD |
Environmental Carcinogenesis and Mutagenesis |
University of Cincinnati (Ntl Inst of Environmental Hlth Sciences) National Institues of Health (NIH) |
T32ES007250 |
7/1/2020-8/31/2020 |
$9,126 |
Kaylin G Earnest, PhD |
Earnest T32 2019 |
University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) |
1015348 |
9/1/2020-8/31/2021 |
$60,830 |
Lisa Marie Privette Vinnedge, PhD |
Mechanisms coupling DEK to oncogenesis |
National Cancer Institute National Institues of Health (NIH) |
R01CA218072 |
2/1/2021-1/31/2022 |
$363,712 |
Lisa Marie Privette Vinnedge, PhD |
Privette LIFE-UC 2019 |
University of Cincinnati (Life Sciences Research Foundation) |
LIFE FND 2019 |
11/1/2019-10/31/2020 |
$4,500 |
Lisa Marie Privette Vinnedge, PhD |
Evaluating the role of ionizing radiation induced DNA damage in the developing mammary gland |
University of Cincinnati Cancer Center |
Privette, Lisa, UCCC |
7/1/2020-6/30/2021 |
$50,000 |
Lynn H Lee, MD |
Targeting MBNL1-mediated alternative splicing in MLL-fusion leukemia |
St. Baldrick's Foundation |
AwardID: 638749 |
7/1/2020-6/30/2021 |
$110,000 |
Lynn H Lee, MD |
Targeting MBNL1-mediated alternative splicing in MLL-fusion leukemia |
National Cancer Institute National Institues of Health (NIH) |
K08CA237753 |
3/25/2021-2/28/2022 |
$196,112 |
Maureen O'Brien, MD |
Scientific Advosir Board service |
Alex's Lemonade Stand Foundation |
O'Brien, Maureen ALS |
12/1/2020-11/30/2021 |
$10,000 |
Maureen O'Brien, MD |
O'Brien COG NCTN Study Chair 2019 |
Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) |
U10CA180886 |
3/1/2020-2/28/2021 |
$23,262 |
Megan Johnstone, PhD |
Johnstone T32 |
University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) |
1014415 |
9/1/2020-8/31/2021 |
$55,596 |
Megan Johnstone, PhD |
Investigating the role of ovarian hormones on secondary breast cancer risk following radiation therapy during puberty |
Cancer Free Kids |
Johnstone, M., CFK |
7/1/2020-6/30/2021 |
$50,000 |
Michael J Absalon, MDPhD |
A Phase I Study of Venetoclax and Vyxeos (CPX-351) for Children, Adolescents, and Young Adults with Relapsed Acute Leukemia |
Michigan State University (Conquer Cancer Foundation) |
RC111290 CHMC |
7/1/2020-6/30/2021 |
$46,500 |
Natasha Pillay-Smiley, DO |
Pilay Smiley / Lurie / LGG14C03 |
Lurie Children's Hospital of Chicago |
LGG-14C03 |
8/17/2020-8/16/2025 |
$2,001 |
Natasha Pillay-Smiley, DO |
The Pediatric Brain Tumor Consortium |
St Jude's Children's Hospital (National Cancer Institute) National Institues of Health (NIH) |
110068210-7947557 |
5/22/2020-3/31/2021 |
$88,444 |
Natasha Pillay-Smiley, DO |
The Pediatric Brain Tumor Consortium |
St Jude's Children's Hospital (National Cancer Institute) National Institues of Health (NIH) |
110068210-7947557 |
5/22/2020-3/31/2021 |
$26,175 |
Peter Matthew Kennedy de Blank, MD |
De Blank NIH-COG |
Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) |
20115662 - RSUB |
3/1/2019-2/28/2021 |
$30,819 |
Rajaram Nagarajan, MD |
Research into Visual Endpoints and RB Health Outcomes after Treatment: The RIVERBOAT consortium. |
Vanderbilt University Medical Center (National Cancer Institute) National Institues of Health (NIH) |
VUMV67585 |
8/1/2020-7/31/2021 |
$22,821 |
Robin E Norris, MD, MPH |
Norris COG Specimen Supplement |
Children's Hospital of Philadelphia (National Institute for Health Research) |
FP00033922_SUB04_01 |
3/1/2020-2/28/2021 |
$5,900 |
Susanne Wells, PhD |
FA Pathway Activities in the Normal and Transformed Epidermis |
National Cancer Institute National Institues of Health (NIH) |
R01CA223790 |
8/1/2020-7/31/2021 |
$363,713 |
Susanne Wells, PhD |
Strengthening epidermal defenses for the prevention of HPV infection and |
National Cancer Institute National Institues of Health (NIH) |
R01CA228113 |
12/1/2020-11/30/2021 |
$367,049 |
Susanne Wells, PhD |
New activities of the human DEK oncogene |
National Cancer Institute National Institues of Health (NIH) |
R01CA239605 |
12/1/2020-11/30/2021 |
$362,374 |
Trent Hummel, MD |
DIPG |
The Cure Starts Now Foundation |
Dewire, DIPG |
12/10/2019-12/9/2020 |
$11 |
Trent Hummel, MD |
Targeting epienetic dysregulation in pediatric cancer |
Dana Farber Cancer Institute (Stand Up to Cancer) |
6332101 |
1/1/2020-12/31/2021 |
$33,797 |
Total Annual Grant Award Dollars |
$3,362,860 |